Urinary biomarkers and risk of ESRD in the atherosclerosis risk in communities study

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 11, 2015, Pages 1956-1963

  Foster, Meredith C ^a   Coresh, Josef ^a   Bonventre, Joseph V ^a   Sabbisetti, Venkata S ^a   Waikar, Sushrut S ^a   Mifflin, Theodore E ^a   Nelson, Robert G ^a   Grams, Morgan ^a   Feldman, Harold I ^a   Vasan, Ramachandran S ^a   Kimmel, Paul L ^a   Hsu, Chi Yuan ^a   Liu, Kathleen D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; EPIDERMAL GROWTH FACTOR RECEPTOR; FATTY ACID BINDING PROTEIN; GLUCOSE; KIDNEY INJURY MOLECULE 1; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; FEMALE; HUMAN; KIDNEY FUNCTION; LIMIT OF DETECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; URINALYSIS; COMPLICATION; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; RISK; RISK ASSESSMENT; URINE;

ATHEROSCLEROSIS; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; RISK ASSESSMENT;

EID: 84946751658     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02590315     Document Type: Article

References (22)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
2. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
3. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative metaanalysis. Lancet 375: 2073-2081, 2010
4. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J; Chronic Kidney Disease Prognosis Consortium: Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80: 93-104, 2011
5. Peralta CA, Katz R, Bonventre JV, Sabbisetti V, Siscovick D, Sarnak M, Shlipak MG: Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 60: 904-911, 2012
6. Bhavsar NA, Köttgen A, Coresh J, Astor BC: Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 60: 233-240, 2012
7. Smith ER, Lee D, Cai MM, Tomlinson LA, Ford ML, McMahon LP, Holt SG: Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD). Nephrol Dial Transplant 28: 1569-1579, 2013
8. Liu KD, Yang W, Anderson AH, Feldman HI, Demirjian S, Hamano T, He J, Lash J, Lustigova E, Rosas SE, Simonson MS, Tao K, Hsu CY; Chronic Renal Insufficiency Cohort (CRIC) study investigators: Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease. Kidney Int 83: 909-914, 2013
9. The Atherosclerosis Risk in Communities: The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. The ARIC investigators. Am J Epidemiol 129: 687-702, 1989
10. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
11. Bash LD, Astor BC, Coresh J: Risk of incident ESRD: A comprehensive look at cardiovascular risk factors and 17 years of followup in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 55: 31-41, 2010
12. Astor BC, Shafi T, Hoogeveen RC, Matsushita K, Ballantyne CM, Inker LA, Coresh J: Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis 59: 653-662, 2012
13. Foster MC, Coresh J, Fornage M, Astor BC, Grams M, Franceschini N, Boerwinkle E, Parekh RS, Kao WH: APOL1 variants associate with increased risk of CKD among African Americans. J Am Soc Nephrol 24: 1484-1491, 2013
14. Rebholz CM, Coresh J, Ballew SH, McMahon B, Whelton SP, Selvin E, Grams ME: Kidney failure and ESRD in the Atherosclerosis Risk in Communities (ARIC) Study: Comparing ascertainment of treated and untreated kidney failure in a cohort study. Am J Kidney Dis 66: 231-239, 2015
15. Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Bonventre JV, Sabbisetti V, Waikar SS, Mifflin TE, Zhang X, Xie D, Hsu CY, Feldman HI, Coresh J, Vasan RS, Kimmel PL, Liu KD; Chronic Kidney Disease Biomarkers Consortium Investigators: Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus. Diabetologia 58: 188-198, 2015
16. Panduru NM, Forsblom C, Saraheimo M, Thorn L, Bierhaus A, Humpert PM, Groop PH; FinnDiane Study Group: Urinary livertype fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 36: 2077-2083, 2013
17. Kamijo-Ikemori A, Sugaya T, Yasuda T, Kawata T, Ota A, Tatsunami S, Kaise R, Ishimitsu T, Tanaka Y, Kimura K: Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients. Diabetes Care 34: 691-696, 2011
18. Park HC, Hwang JH, Kang AY, Ro H, Kim MG, An JN, In Park J, Kim SH, Yang J, Oh YK, Oh KH, Noh JW, Cheong HI, Hwang YH, Ahn C: Urinary N-acetyl-b-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study. BMC Nephrol 13: 93, 2012
19. Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI; CRIC Study Investigators: Association of kidney disease outcomes with risk factors for CKD: Findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis 63: 236-243, 2014
20. Waikar SS, Sabbisetti VS, Bonventre JV: Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int 78: 486-494, 2010
21. Virgili F, Maiani G, Zahoor ZH, Ciarapica D, Raguzzini A, Ferro-Luzzi A: Relationship between fat-free mass and urinary excretion of creatinine and 3-methylhistidine in adult humans. J Appl Physiol (1985) 76: 1946-1950, 1994
22. Wilson FP, Xie D, Anderson AH, Leonard MB, Reese PP, Delafontaine P, Horwitz E, Kallem R, Navaneethan S, Ojo A, Porter AC, Sondheimer JH, Sweeney HL, Townsend RR, Feldman HI; CRIC Study Investigators: Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: The CRIC study. Clin J AmSoc Nephrol 9: 2095-2103, 2014